[Use of anaplyxasis for evaluating the reactogenicity of commercial strains and series of a vaccine virus].
D000707:Anaphylaxis / Q000276:immunology*; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D002417:Cattle; D005260:Female; D006168:Guinea Pigs; D006389:Hemagglutinins, Viral / Q000032:analysis; D008297:Male; D009500:Neutralization Tests; D013997:Time Factors; D014611:Vaccination; D014616:Vaccinia virus / Q000276:immunology*; D014765:Viral Vaccines / Q000276:immunology*; D014776:Virus Cultivation
D000914:Antibodies, Viral; D006389:Hemagglutinins, Viral; D014765:Viral Vaccines
Primenenie anafilaksii dlia otsenki reaktogennosti proizvodstvennykh shtammov i seriĭ virusa vaktsiny.